The United Kingdom (UK) will no longer be eligible for initial VHPs and VHP-substantial amendments (VHP-SA) starting with 1 November 2020.
More information: https://www.hma.eu/fileadmin/dateien/Human_Medicines/01-About_HMA/Working_Groups/CTFG/2020_10_VHP_brexit_and_Christmas_Break.pdf
Department of Clinical Trials on Medicinal Products
Date: 3 November 2020
cz